N-glycosylation as novel strategy to improve pharmacokinetic properties of bispecific single-chain diabodies (Q40021987)

16 September 2017

title

N-glycosylation as novel strategy to improve pharmacokinetic properties of bispecific single-chain diabodies (English)

1 reference

16 September 2017

1 reference

1 reference

Roland Stork

1 reference

16 September 2017

Kirstin A Zettlitz

1 reference

16 September 2017

Dafne Müller

1 reference

16 September 2017

Miriam Rether

1 reference

16 September 2017

Franz-Georg Hanisch

1 reference

16 September 2017

Roland E Kontermann

1 reference

16 September 2017

language of work or name

English

0 references

publication date

22 January 2008

1 reference

Journal of Biological Chemistry

16 September 2017

published in

1 reference

16 September 2017

volume

283

1 reference

16 September 2017

1 reference

16 September 2017

page(s)

7804-7812

1 reference

Antibody pharmacokinetics and pharmacodynamics

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709179200

Advances in allergen-specific immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709179200

Pharmacology and biological efficacy of a recombinant, humanized, single-chain antibody C5 complement inhibitor in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709179200

Eradication of tumors from a human colon cancer cell line and from ovarian cancer metastases in immunodeficient mice by a single-chain Ep-CAM-/CD3-bispecific antibody construct

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709179200

Pharmacokinetic and pharmacodynamic considerations in the development of therapeutic proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709179200

Pharmaceutical strategies utilizing recombinant human serum albumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709179200

Polymer conjugates as anticancer nanomedicines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709179200

PEGylated antibodies and antibody fragments for improved therapy: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709179200

Effect of pegylation on pharmaceuticals

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709179200

Rational design of a potent, long-lasting form of interferon: a 40 kDa branched polyethylene glycol-conjugated interferon alpha-2a for the treatment of hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709179200

Imaging tumors with an albumin-binding Fab, a novel tumor-targeting agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709179200

The pharmacokinetics of an albumin-binding Fab (AB.Fab) can be modulated as a function of affinity for albumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709179200

A phase 2 study to evaluate the antiviral activity, safety, and pharmacokinetics of recombinant human albumin-interferon alfa fusion protein in genotype 1 chronic hepatitis C patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709179200

Enhancement of therapeutic protein in vivo activities through glycoengineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709179200

Glycoengineering: the effect of glycosylation on the properties of therapeutic proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709179200

Development and characterization of novel erythropoiesis stimulating protein (NESP)

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709179200

Glycosylation of an N-terminal extension prolongs the half-life and increases the in vivo activity of follicle stimulating hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709179200

Long-acting follicle-stimulating hormone analogs containing N-linked glycosylation exhibited increased bioactivity compared with o-linked analogs in female rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709179200

Characterization of site-specific ScFv PEGylation for tumor-targeting pharmaceuticals

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709179200

Phage libraries for generation of clinically useful antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709179200

Transmembrane and secreted MUC1 probes show trafficking-dependent changes in O-glycan core profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709179200

Pharmacokinetic and tumor-seeking properties of recombinant and nonrecombinant anti-carcinoembryonic antigen antibody fragments

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709179200

Mutation of any site of N-linked glycosylation accelerates the in vivo clearance of recombinant rabbit antithrombin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709179200

Effect of carbohydrates on the pharmacokinetics of human interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709179200

The pharmacokinetic pattern of glycosylated human recombinant lymphotoxin (LT) in rats after intravenous administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709179200

Single-chain Fv with manifold N-glycans as bifunctional scaffolds for immunomolecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709179200

Structural variability of BM-40/SPARC/osteonectin glycosylation: implications for collagen affinity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709179200

Glycosylation of recombinant antibody therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709179200

Metabolic control of recombinant protein N-glycan processing in NS0 and CHO cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709179200

Structural characterization of TSC-36/Flik: analysis of two charge isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709179200

Structural characterization of human recombinant and bone-derived bone sialoprotein. Functional implications for cell attachment and hydroxyapatite binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709179200

A new Chinese hamster ovary cell line expressing alpha2,6-sialyltransferase used as universal host for the production of human-like sialylated recombinant glycoproteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709179200

Amino acid domains control the circulatory residence time of primate acetylcholinesterases in rhesus macaques (Macaca mulatta).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709179200

PEGylation and multimerization of the anti-p185HER-2 single chain Fv fragment 4D5: effects on tumor targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709179200

Protein PEGylation decreases observed target association rates via a dual blocking mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709179200

A passionate kiss, then run: exocytosis and recycling of IgG by FcRn.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709179200

The major histocompatibility complex-related Fc receptor for IgG (FcRn) binds albumin and prolongs its lifespan

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709179200

21 January 2018

Identifiers

DOI

10.1074/JBC.M709179200

1 reference

16 September 2017

1 reference